Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7582475 | 7995420 | F | 7582475-2 | 20110509 | 20110622 | 20110630 | EXP | JP-JNJFOC-20110606271 | ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. | 80 | YR | F | Y | 20110630 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7582475 | 1016900968 | C | GRAMALIL | 2 | ORAL | ||||||
| 7582475 | 1016900965 | SS | GALANTAMINE HYDROBROMIDE | 1 | ORAL | ||||||
| 7582475 | 1016900967 | C | VALSARTAN/HYDROCHLOROTHIAZIDE | 1 | ORAL | ||||||
| 7582475 | 1016900966 | PS | GALANTAMINE HYDROBROMIDE | 1 | ORAL | 021169 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7582475 | 1016900965 | DEMENTIA ALZHEIMER'S TYPE |
| 7582475 | 1016900967 | HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7582475 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 7582475 | PERSECUTORY DELUSION |
| 7582475 | AGITATION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7582475 | 1016900968 | 20110511 | |||
| 7582475 | 1016900965 | 20110328 | 20110425 | ||
| 7582475 | 1016900967 | 20110128 | |||
| 7582475 | 1016900966 | 20110426 | 20110509 |